Exchange: NASDAQ·Updated 06:53 PM EDT
TEM logo

TEM Tempus AI Inc

$67.03
$0.10
(0.15%)
Today
Closed $68.32
$1.29
(1.89%)
After Hours
EarningsNov 3
Mkt Cap$12.31B
Vol6.04M

About TEM

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
47

Neutral Sentiment

How do you feel about TEM?

DaddyKnows
$TEM once shorts finish covering we gonna dump probably around 10 dollars. Still waitin for that 69 gap close. Daddy more patient then these wanna be gamblers.
3
2
Shaffin786
$TEM Tempus AI is building one of the most compelling growth platforms in healthcare, combining clinical data, diagnostics and artificial intelligence to make medicine smarter and more personalized. Its expanding data network, growing testing business and deep relationships across healthcare create powerful long-term advantages. As more hospitals, physicians and pharmaceutical companies use Tempus, the platform can become increasingly valuable and difficult to replicate. If execution remains strong, TEM has the potential to compound growth for years and emerge as one of the defining healthcare technology companies of the AI era ahead.
1
6
USMC223556
$TEM TEMPUS AI — THE TIME IS NOW Since October 2025 TEMP has faced heavy corporate short selling while retail traders have added pressure by flipping for small gains instead of holding for larger gains. That activity brought TEMP to a 52-week low of $40.77 on July 28 2026. On Friday September 25 2026 TEMP closed at $85.01 — up more than 108% in roughly 8½ weeks. Think of TEMP as a rubber ball held underwater. Corporate short sellers and trading activity are holding it down. But TEMP’s fundamentals are accelerating at a rapid pace building the force that will pop that ball right out of the water. On September 24 2026 Zacks published an article recommending three AI-powered medical stocks to strengthen your portfolio: Intuitive Surgical $405.18 Thermo Fisher Scientific $675 and Tempus AI $85.01. Zacks expects TEMP’s 2027 earnings growth to exceed 100%. TEMP has climbed more than 108% from $40.77 to $85.01 while the business continues gaining momentum. $600+ someday? Very possible.
9
dixiebull
$TEM got 84 , could dip to 82 and watch for a bounce there or break of 84 to 85 and 88 $SDGR strong day to 33, see if 32 can hold, better 32.50, for amove to 35 and 36.50 $AAOX swing from 12 got 13.85, see if 13.50 holds for 15 $MRNA had 200 res then broke to 205.77, if 200 canhold it can kepe on to 205 and 210
1
5
CR7LOVE
$TEM bullish trend still intact. Sitting at lower trend line. Looking for a bounce here
6
Jonathan408
$TEM 💥💯💰💰💰💰💰💯💥 EXTREMELY BULLISH SETUP! Double-bottom support near $66.85 is holding strong, price reclaimed both converging EMAs, RSI surged from 16.7 to 53.7, and MACD flipped bullish with an expanding positive histogram. Momentum is shifting decisively toward the bulls, setting the stage for a potential breakout and powerful squeeze!💥🚀💰🏆
5
Caligrlsd
$TEM only good news 1.Personalis-Tempus merger clears key regulatory milestone 2.Partnership extended for 7 years with Merck and Moderna What else do we need to move this back? Souls be a GREEN DAY.
7
AlertsAndNews
$TEM $MRNA $MRK TEM Tempus Announces Multi-Year Collaboration with Moderna and Merck "oday announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157), a novel, potential first-in-class individualized neoantigen therapy (INT) being evaluated in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with completely resected stage IIB-IV melanoma and other cancer types. Intismeran autogene is jointly developed by Moderna and Merck, known as MSD outside of the United States and Canada. The collaboration builds on joint efforts initiated last year and will support preparations for the potential commercialization of intismeran autogene."
1
4
NotStockGuru
$TEM If there were a Guinness World Record for the person with the world's worst luck, I could have easily won that.
7
OptionsJohnny
$TEM: Bullish Right Angle Descending Megaphone break out and measured move price target attainment.
1
4
Jonathan408
$TEM 💥💯🚀💥💯🚀💥💯🚀💥💯🚀 The oversold bounce is forming & RSI is curling out! Time for a nice bounce & accumulation time.
5
Jonathan408
$TEM 🚨 Earnings Nov 3 after hours, and the track record speaks for itself! 🚀 ✅ 4 straight EPS beats: +36%, +3%, +35%, and +72% last quarter 💥 ✅ 4 straight revenue beats too: $334M → $367M → $348M → $382M 📈 💰 Q3 estimate: $409M revenue, another step up from last quarter. TEM is green at $69+ and keeps beating the Street. The setup into earnings is loaded. 🔥 Bulls, let's go! 💯💥🚀💰🥳
3
ABELTR
$TEM this company is the future in medicine. Very much needed. The management team must be thinkers and I Bbelive they are. Innvators. 100 plus soon and on to a gusher, bam !
1
3
Cadi2519
$TEM Looking forward to this week. Hopefully we can make some moves up to 75, then 85 after.
5
Cadi2519
$TEM Not too worried. Just general macros after the attacks this weekend on the Saudi airport.
4
Frdmin8
$TEM wow what a close great big buys end of day ! You are holding a lot of gold TEM ers !
5
Andrewsan85
$TEM When the stock goes up, I’ve got a huge grin on my face. When it drops hard, I’ve got the exact same grin on my face and buy the damn dip!” 📈😂�
4
krill97
$TEM bought 1000 shares at $73.80. Will continue to buy if it keeps going lower and dollar cost average. Why try to catch a bottom
5
NotStockGuru
$TEM Here is my analysis: today will close at about 72ish, tomorrow the range will be 73 to 70ish, and Thursday it might go to 78ish.
1
2
shortking
$TEM Healthcare is the beast! Democrats who are champions of healthcare and clinical research will be back in charge here shortly…You can sell your shares if you want to…$250 easily…
1
2

Advertisement|Remove ads.